Clinical trial
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or…
NCT00098371 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00098371 |
|---|---|
| Title | Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia |
| Official title | A Phase II Study of Flavopiridol Administered as a 30 Minute Loading Dose Followed by a 4-Hour Continuous Infusion in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From CLL |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | alvocidib |
| Enrollment | 64 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Nov 1, 2012 |
| First posted | Dec 8, 2004 |
| Last update posted | Oct 24, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: